D. Perlman

发表

Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program.

D. Mandelman, N. Salomon, D. Perlman, 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?

D. D. Des Jarlais, H. Hagan, S. Tross, 2015, PloS one.

Racial/Ethnic Disparities at the End of an HIV Epidemic: Persons Who Inject Drugs in New York City, 2011-2015

D. D. Des Jarlais, S. Tross, S. Friedman, 2017, American journal of public health.

Predictors and outcome of multidrug-resistant tuberculosis.

B. Kreiswirth, N. Salomon, D. Perlman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculosis in drug users.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program

N. Salomon, D. Perlman, C. Trinh, 2001, Journal of Urban Health.

Syphilis in drug users in low and middle income countries.

D. D. Des Jarlais, H. Hagan, D. Perlman, 2010, The International journal on drug policy.

Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

D. D. Des Jarlais, D. Perlman, J. Feelemyer, 2015, Journal of addictive diseases.

Viral Hepatitis Among Drug Users in Methadone Maintenance: Associated Factors, Vaccination Outcomes, and Interventions

D. D. Des Jarlais, K. Delucchi, J. Sorensen, 2014, Journal of addictive diseases.

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG).

W. El-Sadr, N. Salomon, D. Perlman, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

“Informed Altruism” and “Partner Restriction” in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990–2001

D. D. Des Jarlais, H. Hagan, S. Friedman, 2004, Journal of acquired immune deficiency syndromes.

Quality of care in patients with chronic hepatitis C virus infection.

D. D. Des Jarlais, D. Perlman, A. Talal, 2011, Annals of internal medicine.

Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance.

R. Portenoy, D. Perlman, M. Cheatle, 2015, Drug and alcohol dependence.

Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs.

K. Delucchi, B. Schackman, B. Linas, 2018, Drug and alcohol dependence.

Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

D. D. Des Jarlais, D. Perlman, A. Talal, 2013, Journal of substance abuse treatment.

Imported plague--New York City, 2002.

D. Weiss, K. Gage, P. Reynolds, 2003, MMWR. Morbidity and mortality weekly report.

Eliminating Racial/Ethnic Disparities in AIDS Clinical Trials in the United States: A Qualitative Exploration of an Efficacious Social/Behavioral Intervention.

N. Leonard, D. Perlman, C. Cleland, 2017, Journal of AIDS & clinical research.

Treatment of tuberculosis in HIV-infected patients: we need to know more.

D. Perlman, C. Leung, W. Yew, 2007, American journal of respiratory and critical care medicine.

Multipurpose Prevention Technologies: A Global Sexual and Reproductive Health Priority

M. Reading, V. Guilamo-Ramos, D. Perlman, 2018, The Journal of the Association of Nurses in AIDS Care : JANAC.

Mycobacterial infections of the head and neck

N. Salomon, D. Perlman, R. D’Amico, 2001, Current infectious disease reports.

Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.

D. Peterson, L. Picker, L. Bermudez, 2005, AIDS research and human retroviruses.

Fulminant ecchymosis as the initial manifestation of antiphospholipid syndrome (APS) triggered by respiratory syncytial virus (RSV) infection: A case report and review of the literature

D. Perlman, J. Makino, Sanjana C. Koshy, 2016, IDCases.

Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis

D. D. Des Jarlais, H. Hagan, D. Perlman, 2017, International journal of STD & AIDS.

Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program.

D. D. Des Jarlais, N. Salomon, D. Perlman, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG).

J P Matts, W. El-Sadr, N. Salomon, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penicillium marneffei infection in an immunocompromised traveler: a case report and literature review.

D. Perlman, H. Hofflich, J. Protic, 2006, Journal of travel medicine.

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.

D. D. Des Jarlais, D. Nash, K. Arasteh, 2015, Drug and alcohol dependence.

The HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysis

H. Hagan, D. Perlman, Ashly E. Jordan, 2016, Systematic Reviews.

Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.

B. Schackman, D. Nash, K. Wyka, 2020, The Journal of infectious diseases.

Directly observed treatment of tuberculosis.

N. Salomon, D. Perlman, 1993, The New England journal of medicine.

Toward a Theory of the Underpinnings and Vulnerabilities of Structural Racism: Looking Upstream from Disease Inequities among People Who Use Drugs

S. Friedman, P. Mateu-Gelabert, D. Perlman, 2022, International journal of environmental research and public health.

Behavioral Intervention Improves Treatment Outcomes Among HIV-Infected Individuals Who Have Delayed, Declined, or Discontinued Antiretroviral Therapy: A Randomized Controlled Trial of a Novel Intervention

H. Wolfe, N. Leonard, M. Riedel, 2015, AIDS and Behavior.

Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic”

D. D. Jarlais, H. Hagan, S. Tross, 2016, AIDS and Behavior.

Directly observed therapy and treatment adherence

N. Salomon, D. Perlman, 2000, The Lancet.

Knowledge of hepatitis among active drug injectors at a syringe exchange program.

D. D. Des Jarlais, D. Perlman, P. Friedmann, 2005, Journal of substance abuse treatment.

Chronic High Risk Prescription Opioid Use Among Persons With HIV

D. Cain, J. Aberg, D. Perlman, 2021, Frontiers in Sociology.

Organizational issues in conducting tuberculosis screening at a syringe exchange program.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1998, Journal of substance abuse treatment.

"Shotgunning" as an illicit drug smoking practice.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1997, Journal of substance abuse treatment.

Two-stage tuberculin skin testing in an HIV-infected population: a preliminary report.

N. Salomon, D. Perlman, S. Goldstein, 1994, The Mount Sinai journal of medicine, New York.

Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infections in Otolaryngology

D. Perlman, C. Kimmelman, M. Shah, 1992, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange.

S. Stancliff, N. Salomon, D. Perlman, 2000, Journal of substance abuse treatment.

Tuberculosis in patients with human immunodeficiency virus infection.

N. Salomon, D. Perlman, P. El-Helou, 1999, Seminars in respiratory infections.

Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001-2005 and 2011-2015.

D. D. Des Jarlais, S. Tross, K. Arasteh, 2018, Drug and alcohol dependence.

Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities

P. Mateu-Gelabert, D. Perlman, H. Guarino, 2022, Substance use & misuse.

Responding to a surge in overdose deaths: perspectives from US syringe services programs

D. D. Des Jarlais, B. Schackman, E. Williams, 2022, Harm Reduction Journal.

Current and Emerging Research Needs in Studying the NYC HIV–Drug Use Epidemic

D. D. Des Jarlais, H. Hagan, S. Friedman, 2011, Substance use & misuse.

Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy

S. Sarkar, D. Perlman, E. Azar, 2007, Scandinavian journal of infectious diseases.

Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.

B. Schackman, D. Nash, K. Wyka, 2020, The Journal of infectious diseases.

Putative invasive pulmonary aspergillosis in critically ill patients with COVID‐19: An observational study from New York City

N. Salomon, D. Perlman, W. Javaid, 2020, Mycoses.

Persistent Yersinia pestis antigens in ischemic tissues of a patient with septicemic plague.

J. Guarner, J. Kool, K. Gage, 2005, Human pathology.

HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.

D. D. Des Jarlais, L. Torian, H. Hagan, 2010, Drug and alcohol dependence.

Giant cellulitis-like Sweet syndrome: An underrecognized clinical variant mimicking skin and soft tissue infection

D. Perlman, S. Yancovitz, J. Saabiye, 2020, IDCases.

Fluoroquinolone- and ceftriaxone-based therapy of community-acquired pneumonia in hospitalized patients: the risk of subsequent isolation of multidrug-resistant organisms.

D. Perlman, D. Mildvan, T. Jodlowski, 2014, American journal of infection control.

“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives

P. Mateu-Gelabert, D. Perlman, H. Guarino, 2021, Harm Reduction Journal.

Aspergillosis in the acquired immunodeficiency syndrome.

N. Salomon, D. Perlman, W. Talavera, 1991, Chest.

Editorial Response: Multidrug-Resistant Tuberculosis—Globally with Us for the Long Haul

N. Salomon, D. Perlman, 1999 .

Why some injection drug users lick their needles: a preliminary survey.

D. Perlman, M. Deutscher, 2008, The International journal on drug policy.

Pneumonia and bacteremia due to Serratia odorifera.

D. Perlman, J. Carey, Jungmin Lee, 2006, Journal of Infection.

Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses: A “Big Events” Perspective

S. Friedman, P. Mateu-Gelabert, D. Perlman, 2022, International journal of environmental research and public health.

Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.

D. D. Des Jarlais, H. Hagan, S. Friedman, 2009, Drug and alcohol dependence.

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.

D. D. Des Jarlais, S. Tross, A. Uusküla, 2018, Drug and alcohol dependence.

Can intranasal drug use reduce HCV infection among injecting drug users?

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2011, Drug and alcohol dependence.

Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol

L. Collins, R. Braithwaite, N. Leonard, 2017, BMC Public Health.

Experience with a cross‐study endpoint review committee for AIDS clinical trials

J. Neaton, R. Price, F. Rhame, 1998, AIDS.

Big Events theory and measures may help explain emerging long-term effects of current crises

S. Friedman, P. Mateu-Gelabert, M. Cerdá, 2021, Global public health.

Reconsidering Assumptions of Adolescent and Young Adult Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Dynamics

V. Guilamo-Ramos, D. Perlman, Adam Benzekri, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical features and outcome of HIV‐related cytomegalovirus pneumonia

C. Eber, N. Salomon, D. Perlman, 1997, AIDS.

Nested Case-Control Study of the Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae

D. Perlman, D. Mildvan, T. Jodlowski, 2013, Antimicrobial Agents and Chemotherapy.

Prevention of Disseminated Penicillium marneffei in human immunodeficiency virus-infected Travelers.

D. Perlman, J. Carey, 2006, Journal of travel medicine.

Isospora belli infection: treatment with pyrimethamine.

L. Weiss, H. Tanowitz, D. Perlman, 1988, Annals of internal medicine.

M. Motyl, D. Perlman, J. Carey, 2001, Emerging infectious diseases.

Epidural Empyema Secondary to Extension of Fulminant Paranasal Sinusitis The Significance of Actinomyces meyeri

D. Perlman, J. Makino, S. Bajaj, 2016 .

Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.

D. D. Des Jarlais, D. Perlman, M. Yancovitz, 2001, American journal of public health.

Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons

D. Lucido, N. Salomon, D. Perlman, 2014, International journal of STD & AIDS.

Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine

D. D. Des Jarlais, B. Schackman, E. Williams, 2022, Journal of addiction medicine.

A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.

D. D. Des Jarlais, K. Delucchi, J. K. Manuel, 2013, American journal of public health.

Organizational Issues in the Implementation of a Hospital-Based Syringe Exchange Program

D. D. Des Jarlais, J. Sorensen, D. Perlman, 2010, Substance use & misuse.

Impact of monetary incentives on adherence to referral for screening chest X-rays after syringe exchange-based tuberculin skin testing

D. D. Des Jarlais, V. Schoeb, N. Salomon, 2003, Journal of Urban Health.

Tuberculosis screening at a syringe exchange program.

D. D. Des Jarlais, D. Perlman, M. Perkins, 1997, American journal of public health.

A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.

W. El-Sadr, D. Perlman, E. Denning, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua

D. Nash, D. Perlman, Ashly E. Jordan, 2017, Front. Public Health.

Perceptions of drug users regarding Hepatitis C screening and care: a qualitative study

P. Mateu-Gelabert, J. Sorensen, D. Perlman, 2013, Harm Reduction Journal.

Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci.

S. Handwerger, D. Perlman, V. Mcauliffe, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)

C. del Rio, L. Metsch, D. Feaster, 2021, Open forum infectious diseases.

Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.

D. Perlman, A. Jordan, 2015, The International journal on drug policy.

Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.

Sandra E. Larios, D. D. Des Jarlais, J. Sorensen, 2014, Journal of substance abuse treatment.

Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020

D. D. Des Jarlais, B. Schackman, D. Perlman, 2022, Drug and Alcohol Dependence.

A focus of Rocky Mountain spotted fever within New York City.

J. Casey, M. Levi, J. Benach, 1988, The New England journal of medicine.

Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation.

B. Schackman, D. Nash, K. Wyka, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Application of an adapted PRECIS-2 instrument to assess efficacy- and effectiveness-study designs in a systematic review of intervention studies of the hepatitis C virus-care continuum among people who use drugs

H. Hagan, D. Perlman, Daniel J. Smith, 2018 .

The Opioid/Overdose Crisis as a Dialectics of Pain, Despair, and One-Sided Struggle

S. Friedman, P. Mateu-Gelabert, M. Cerdá, 2020, Frontiers in Public Health.

Epidemiology of pain among outpatients in methadone maintenance treatment programs.

R. Portenoy, D. Perlman, P. Homel, 2013, Drug and alcohol dependence.

Outcomes of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor use in neutropenic patients infected with human immunodeficiency virus.

N. Salomon, D. Perlman, B. Ambati, 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Risk Factors for Positive Follow-Up Blood Cultures in Gram-Negative Bacilli Bacteremia: Implications for Selecting Who Needs Follow-Up Blood Cultures

D. Perlman, H. Mitaka, Young Im Lee, 2020, Open forum infectious diseases.

Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of COVID-19: Lessons Unlearned from AIDS Denialism

D. Perlman, J. Jaiswal, C. LoSchiavo, 2020, AIDS and Behavior.

The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions

D. Perlman, A. Jordan, 2018, Current HIV/AIDS Reports.

Theory, Measurement and Hard Times: Some Issues for HIV/AIDS Research

S. Friedman, P. Mateu-Gelabert, M. Sandoval, 2013, AIDS and Behavior.

What happened to the HIV epidemic among non‐injecting drug users in New York City?

D. D. Des Jarlais, H. Hagan, S. Tross, 2017, Addiction.

Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives

B. Schackman, E. Williams, D. Perlman, 2022, International Journal of Drug Policy.

Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2011, American journal of public health.

Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.

D. D. Des Jarlais, B. Schackman, D. Perlman, 2018, Journal of acquired immune deficiency syndromes.

Hospital- versus community-based syringe exchange: a randomized controlled trial.

S. Hall, D. D. Des Jarlais, K. Delucchi, 2007, AIDS education and prevention : official publication of the International Society for AIDS Education.

HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, PloS one.

Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City

D. Perlman, D. Ompad, S. Walters, 2021, Substance use & misuse.

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, AIDS and Behavior.

Medical service use and financial charges among opioid users at a public hospital.

K. Delucchi, J. Sorensen, S. Batki, 2002, Drug and alcohol dependence.

A case of purulent gonococcal arthritis

D. Perlman, M. Vidaurrazaga, 2019, IDCases.

Perceptions of genetic testing and genomic medicine among drug users.

H. Hagan, S. Friedman, D. Perlman, 2015, The International journal on drug policy.

Perceptions of genetic testing and genomic medicine among urban drug users

D. Perlman, 2013 .

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

D. D. Des Jarlais, B. Schackman, D. Perlman, 2015, The International journal on drug policy.

Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City

H. Hagan, S. Jenness, N. Leonard, 2017, Journal of acquired immune deficiency syndromes.

Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.

D. D. Des Jarlais, H. Hagan, S. Friedman, 2009, American journal of public health.

PersistenceandChangeinDisparitiesinHIVInfection AmongInjectionDrugUsersinNewYorkCityAfter Large-ScaleSyringeExchangePrograms

H. Hagan, S. Friedman, K. Arasteh, 2009 .

Sexual Risk and HIV Infection Among Drug Users in New York City: A Pilot Study

D. D. Des Jarlais, H. Hagan, D. Perlman, 2011, Substance use & misuse.

Notes on harm reduction and the opioid epidemic in the United States

D. Perlman, J. Feelemyer, D. C. Jarlais, 2021 .

The Flawed Reliance on Randomized Controlled Trials in Studies of HIV Behavioral Prevention Interventions for People Who Inject Drugs and Other Populations

S. Friedman, D. Perlman, D. Ompad, 2015, Substance use & misuse.

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial

L. Metsch, D. Feaster, B. Schackman, 2016, Trials.

Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care: a single arm exploratory trial using respondent-driven sampling

H. Hagan, N. Leonard, D. Perlman, 2015, BMC Public Health.

Strategies to uncover undiagnosed HIV infection among heterosexuals at high risk and link them to HIV care with high retention: a “seek, test, treat, and retain” study

H. Hagan, S. Jenness, N. Leonard, 2015, BMC Public Health.

Considerations for the Development of a Substance-Related Care and Prevention Continuum Model

D. Perlman, A. Jordan, 2017, Front. Public Health.

Doing a shotgun: a drug use practice and its relationship to sexual behaviors and infection risk.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1999, Social science & medicine.

Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV‐related tuberculosis and characterization of a strain with levofloxacin monoresistance

John P. Matts, James M. Musser, J. Musser, 1997 .

Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results

L. Metsch, D. Feaster, B. Schackman, 2020, Medical care.

A Perfect Storm: Crack Cocaine, HSV-2, and HIV Among Non-Injecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, Substance use & misuse.

Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis.

H. Hagan, D. Perlman, Jennifer Reed, 2018, Journal of clinical epidemiology.

Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.

K. Sepkowitz, W. El-Sadr, C. Benson, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs

H. Hagan, D. Perlman, Jennifer Reed, 2017, Front. Public Health.

The Shift in Emphasis From Risk-Based to Age-Based Hepatitis C Virus (HCV) Testing in the US Tends to Remove Injection Drug Use From Discourse on HCV

D. Perlman, A. Jordan, 2017, Substance use & misuse.

The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosis.

S. Rosenkranz, N. Salomon, D. Perlman, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Results of Methicillin-Resistant Staphylococcus, aureus Surveillance Culture of Nasal Specimens on Subsequent Antibiotic Prescribing Patterns

B. Kreiswirth, D. Perlman, D. Mildvan, 2010, Infection Control & Hospital Epidemiology.

Preventing opportunistic infections in HIV-infected injection drug users.

D. D. Des Jarlais, N. Salomon, D. Perlman, 1997, JAMA.

Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization

D. D. Des Jarlais, J. Sorensen, M. Shumway, 2017, Journal of ethnicity in substance abuse.

Feasibility of a Computer-Based Intervention Addressing Barriers to HIV Testing Among Young Patients Who Decline Tests at Triage

S. Rajan, D. Perlman, C. Cleland, 2016, Journal of health communication.

ACMHN's 42nd International Mental Health Nursing Conference Nurses striving to tackle disparity in health care 25 - 27 October 2016, Adelaide Convention Centre.

L. Moxham, D. Perlman, Ellie K. Taylor, 2016, International journal of mental health nursing.

Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis.

Cindy R. Friedman, L. Riley, N. Schluger, 1997, The Journal of infectious diseases.

Editorial: The outbreak and sequelae of the increase in opioid use in the United States, Canada, and beyond

S. Friedman, R. DiClemente, D. Perlman, 2022, Frontiers in Sociology.

The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.

S. Rosenkranz, N. Salomon, D. Perlman, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014.

D. D. Des Jarlais, H. Hagan, S. Tross, 2016, American journal of public health.

Association between follow-up blood cultures for gram-negative bacilli bacteremia and length of hospital stay and duration of antibiotic treatment: A propensity score-matched cohort study

T. Kuno, D. Perlman, S. Fujitani, 2022, Infection Control & Hospital Epidemiology.

HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research

J. Sorensen, D. Perlman, C. Masson, 2002, Science & practice perspectives.

Cytomegalovirus pneumonia.

N. Salomon, D. Perlman, 1999, Seminars in respiratory infections.

Use of the “NYC Condom” among People Who Use Drugs

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, Journal of Urban Health.

Gender and Age Patterns in HSV-2 and HIV Infection Among Non-Injecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, S. Friedman, 2010, Sexually transmitted diseases.

Scleritis and endophthalmitis due to Streptococcus pyogenes infective endocarditis.

D. Perlman, H. Mitaka, Tessa Gomez, 2019, The American journal of medicine.

From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.

H. Hagan, S. Tross, K. Arasteh, 2016, Journal of substance abuse treatment.

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021

D. D. Des Jarlais, B. Schackman, D. Perlman, 2022, Public health reports.

Knowledge of tuberculosis among drug users. Relationship to return rates for tuberculosis screening at a syringe exchange.

N. Salomon, D. Perlman, D. C. Jarlais, 1999, Journal of substance abuse treatment.

The experience of respiratory isolation for HIV-infected persons with tuberculosis.

D. Mason, D. Perlman, L. Kelly-Rossini, 1996, The Journal of the Association of Nurses in AIDS Care : JANAC.

Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.

D. D. Des Jarlais, S. Tross, K. Arasteh, 2019, Drug and alcohol dependence.

Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus

D. D. Des Jarlais, H. Hagan, S. Tross, 2017, Sexually transmitted diseases.

Getting Close to Zero New HIV Infections: Consistency in Multiple Methods for Measuring Low HIV Incidence among People Who Inject Drugs in New York City,

H. Hagan, S. Tross, K. Arasteh, 2015 .

Transitions from injecting to non-injecting drug use: potential protection against HCV infection.

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2014, Journal of substance abuse treatment.

HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection

D. D. Des Jarlais, H. Hagan, K. Arasteh, 2013, PloS one.

Herpes Simplex Virus-2 and HIV Among Noninjecting Drug Users in New York City

D. D. Des Jarlais, H. Hagan, S. Friedman, 2007, Sexually transmitted diseases.

Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program

R. D. Bruce, D. Perlman, P. Friedmann, 2013, The American journal of drug and alcohol abuse.

Sociopolitical Diagnostic Tools to Understand National and Local Response Capabilities and Vulnerabilities to Epidemics and Guide Research into How to Improve the Global Response to Pathogens

S. Friedman, D. Perlman, D. Paraskevis, 2023, Pathogens.

AssociationsBetweenHerpesSimplexVirusType2andHCV WithHIVAmongInjectingDrugUsersinNewYorkCity:The CurrentImportanceofSexualTransmissionofHIV

H. Hagan, K. Arasteh, D. Perlman, 2011 .

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

D. D. Des Jarlais, B. Schackman, D. Perlman, 2015, The International journal on drug policy.

Special problems in treating tuberculosis.

N. Salomon, D. Perlman, S. Goldstein, 1994, Annals of internal medicine.

Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs.

C. del Rio, L. Metsch, D. Feaster, 2022, Drug and alcohol dependence.